
Loomis, Sayles & Company’s NeoGenomics NEO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,752,681
| Closed | -$16.6M | – | 775 |
|
2025
Q1 | $16.6M | Sell |
1,752,681
-39,111
| -2% | -$371K | 0.02% | 267 |
|
2024
Q4 | $29.5M | Buy |
1,791,792
+584,502
| +48% | +$9.63M | 0.04% | 201 |
|
2024
Q3 | $17.8M | Buy |
+1,207,290
| New | +$17.8M | 0.02% | 274 |
|
2022
Q1 | – | Sell |
-707,195
| Closed | -$24.1M | – | 1033 |
|
2021
Q4 | $24.1M | Sell |
707,195
-315,745
| -31% | -$10.8M | 0.03% | 282 |
|
2021
Q3 | $49.3M | Sell |
1,022,940
-15,855
| -2% | -$765K | 0.06% | 146 |
|
2021
Q2 | $46.9M | Sell |
1,038,795
-202,902
| -16% | -$9.17M | 0.06% | 163 |
|
2021
Q1 | $59.9M | Sell |
1,241,697
-4,131
| -0.3% | -$199K | 0.08% | 112 |
|
2020
Q4 | $67.1M | Sell |
1,245,828
-7,087
| -0.6% | -$382K | 0.09% | 94 |
|
2020
Q3 | $46.2M | Buy |
1,252,915
+23,787
| +2% | +$878K | 0.07% | 118 |
|
2020
Q2 | $38.1M | Buy |
1,229,128
+106,650
| +10% | +$3.3M | 0.06% | 121 |
|
2020
Q1 | $31M | Buy |
1,122,478
+121,865
| +12% | +$3.36M | 0.06% | 113 |
|
2019
Q4 | $29.3M | Sell |
1,000,613
-3,216
| -0.3% | -$94.1K | 0.05% | 152 |
|
2019
Q3 | $19.2M | Sell |
1,003,829
-130,413
| -11% | -$2.49M | 0.04% | 218 |
|
2019
Q2 | $24.9M | Buy |
1,134,242
+55,542
| +5% | +$1.22M | 0.05% | 178 |
|
2019
Q1 | $22.1M | Sell |
1,078,700
-52,466
| -5% | -$1.07M | 0.04% | 187 |
|
2018
Q4 | $14.3M | Buy |
+1,131,166
| New | +$14.3M | 0.03% | 232 |
|
2016
Q4 | – | Sell |
-608
| Closed | -$5K | – | 1077 |
|
2016
Q3 | $5K | Hold |
608
| – | – | ﹤0.01% | 875 |
|
2016
Q2 | $5K | Hold |
608
| – | – | ﹤0.01% | 850 |
|
2016
Q1 | $4K | Buy |
+608
| New | +$4K | ﹤0.01% | 956 |
|